FMP
SYNLAB AG
SYAB.DE
XETRA
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
10.44 EUR
-0.04 (-0.383%)
About
ceo
Mr. Mathieu Floreani
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.synlab.com
exchange
XETRA
Description
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
CIK
N/A
ISIN
DE000A2TSL71
CUSIP
N/A
Address
Moosacher Straße 88
Phone
49 89 307602 0
Country
DE
Employee
23,538
IPO Date
Apr 30, 2021
Key Executives
